CoChat

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

Open access
Queirós, A C, Villamor, N, Clot, G, Martinez-Trillos, A, Kulis, M, Navarro, A, Penas, E M M, Jayne, S, Majid, A, Richter, J, Bergmann, A K, Kolarova, J, Royo, C, Russiñol, N, Castellano, G, Pinyol, M, Bea, S, Salaverria, I, López-Guerra, M, Colomer, D, Aymerich, M, Rozman, M, Delgado, J, Giné, E, González-Díaz, M, Puente, X S, Siebert, R, Dyer, M J S, López-Otín, C, Rozman, C, Campo, E, López-Guillermo, A, Martín-Subero, J I · 2015 · Leukemia
Cited by 155

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Prospective identification of patients with chronic lymphocytic leukemia (CLL) destined to progress would greatly facilitate their clinical management. Recently, whole-genome DNA methylation analyses identified three clinicobiologic CLL subgroups with an epigenetic signature related to different normal B-cell counterparts. Here, we developed a clinically applicable method to identify these subgroups and to study their clinical relevance. Using a support vector machine approach, we built a prediction model using five epigenetic biomarkers that was able to classify CLL patients accurately into the three subgroups, namely naive B-cell-like, intermediate and memory B-cell-like CLL. DNA methylation was quantified by highly reproducible bisulfite pyrosequencing assays in two independent CLL series. In the initial series (n=211), the three subgroups showed differential levels of IGHV (immunoglobulin heavy-chain locus) mutation (P<0.001) and VH usage (P<0.03), as well as different clinical features and outcome in terms of time to first treatment (TTT) and overall survival (P<0.001). A multivariate Cox model showed that epigenetic classification was the strongest predictor of TTT (P<0.001) along with Binet stage (P<0.001). These findings were corroborated in a validation series (n=97). In this study, we developed a simple and robust method using epigenetic biomarkers to categorize CLLs into three subgroups with different clinicobiologic features and outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2014.252

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 155

Metadata

Authors
Queirós, A. C., Villamor, N., Clot, G., Martinez-Trillos, A., Kulis, M., Navarro, A., Penas, E. M. M., Jayne, S., Majid, A., Richter, J., Bergmann, A. K., Kolarova, J., Royo, C., Russiñol, N., Castellano, G., Pinyol, M., Bea, S., Salaverria, I., López-Guerra, M., Colomer, D., Aymerich, M., Rozman, M., Delgado, J., Giné, E., González-Díaz, M., Puente, X. S., Siebert, R., Dyer, M. J. S., López-Otín, C., Rozman, C., Campo, E., López-Guillermo, A., & Martín-Subero, J. I.
Venue
Leukemia
Published
2014-08-25
Volume
29
Issue
3
Pages
598-605
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2086323499
Cited by
155
References
8
FWCI
5.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.